Simplex Trading’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-63,000
| Closed | -$24K | – | 11999 |
|
|
2021
Q3 | $24K | Hold |
63,000
| – | – | ﹤0.01% | 8301 |
|
|
2021
Q2 | $187K | Buy |
63,000
+62,754
| +25,510% | +$166K | ﹤0.01% | 5792 |
|
|
2021
Q1 | $67K | Buy |
246
+179
| +267% | +$540 | ﹤0.01% | 6265 |
|
|
2020
Q4 | $16K | Buy |
+67
| New | +$161 | ﹤0.01% | 7143 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | -$9K | – | 8853 |
|
|
2020
Q2 | $9K | Sell |
24
-5
| -17% | -$15 | ﹤0.01% | 6740 |
|
|
2020
Q1 | $5K | Buy |
+29
| New | +$75 | ﹤0.01% | 6903 |
|
|
2019
Q4 | – | Sell |
-28
| Closed | -$6K | – | 8277 |
|
|
2019
Q3 | $6K | Hold |
28
| – | – | ﹤0.01% | 6567 |
|
|
2019
Q2 | $8K | Buy |
+28
| New | +$103 | ﹤0.01% | 6264 |
|
|
2019
Q1 | – | Sell |
-77
| Closed | -$34K | – | 8178 |
|
|
2018
Q4 | $34K | Buy |
77
+38
| +97% | +$186 | ﹤0.01% | 4912 |
|
|
2018
Q3 | $18K | Buy |
+39
| New | +$200 | ﹤0.01% | 6058 |
|
Simplex Trading's SBBP Position: Q2 2021 in Review
Simplex Trading sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 241 shares — an estimated $636 sold.
Simplex Trading first reported a position in SBBP in Q1 2019 and held it in 5 quarters. The position peaked at $33K in Q3 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.
- Simplex Trading reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
- Simplex Trading sold 241 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $636.
- Simplex Trading first reported a position in Strongbridge Biopharma plc. in Q1 2019 and held it in 5 quarters.
- Simplex Trading's Strongbridge Biopharma plc. position peaked at $33K in Q3 2020.
- 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.
Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.